(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide

C28H35N5O12 — CID 53318978

IUPAC(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide
SMILESO=C(C[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O
InChIInChI=1S/C28H35N5O12/c34-11-18-23(39)24(40)21(37)16(44-18)8-20(36)31-15(7-12-9-29-14-4-2-1-3-13(12)14)26(42)30-10-17-22(38)25(41)27(45-17)33-6-5-19(35)32-28(33)43/h1-6,9,15-18,21-25,27,29,34,37-41H,7-8,10-11H2,(H,30,42)(H,31,36)(H,32,35,43)/t15-,16+,17+,18+,21-,22+,23-,24+,25+,27+/m0/s1
InChIKeyUKEQCAJAQSXAGO-VXGNVLKZSA-N
MW633.61 g/mol
LogP-4.29
Rot. Bonds10

About (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide

(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide (PubChem CID 53318978) has the molecular formula C28H35N5O12 and a molecular weight of 633.61 g/mol. Its IUPAC name is (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide.

Molecular Properties

Compound Name(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide
PubChem CID53318978
Molecular FormulaC28H35N5O12
Molecular Weight633.61 g/mol
Exact Mass633.23
IUPAC Name(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide
SMILESO=C(C[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O
InChIInChI=1S/C28H35N5O12/c34-11-18-23(39)24(40)21(37)16(44-18)8-20(36)31-15(7-12-9-29-14-4-2-1-3-13(12)14)26(42)30-10-17-22(38)25(41)27(45-17)33-6-5-19(35)32-28(33)43/h1-6,9,15-18,21-25,27,29,34,37-41H,7-8,10-11H2,(H,30,42)(H,31,36)(H,32,35,43)/t15-,16+,17+,18+,21-,22+,23-,24+,25+,27+/m0/s1
InChIKeyUKEQCAJAQSXAGO-VXGNVLKZSA-N
XLogP-4.29
TPSA268.69 Ų
H-Bond Donors10
H-Bond Acceptors13
Rotatable Bonds10
Heavy Atoms45
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500633.61
LogP ≤ 5-4.29
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1013

Analyze (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide?
The IUPAC name of (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide (CID 53318978) is (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide.
What is the SMILES notation for (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide?
The canonical SMILES for (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide is O=C(C[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O.
What is the InChIKey of (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide?
The InChIKey is UKEQCAJAQSXAGO-VXGNVLKZSA-N. The full InChI is InChI=1S/C28H35N5O12/c34-11-18-23(39)24(40)21(37)16(44-18)8-20(36)31-15(7-12-9-29-14-4-2-1-3-13(12)14)26(42)30-10-17-22(38)25(41)27(45-17)33-6-5-19(35)32-28(33)43/h1-6,9,15-18,21-25,27,29,34,37-41H,7-8,10-11H2,(H,30,42)(H,31,36)(H,32,35,43)/t15-,16+,17+,18+,21-,22+,23-,24+,25+,27+/m0/s1.
What are the key properties of (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide?
(2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide has a molecular weight of 633.61 g/mol, XLogP of -4.29, 10 rotatable bonds, 10 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-(1H-indol-3-yl)-2-[[2-[(2R,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]acetyl]amino]propanamide is sourced from PubChem (CID 53318978), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).